Rare diseases
Investigational molecules
Locations
Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma Previously Treated with One Immunotherapy Drug
ItalyStudy on the Effect of Adding Leuprorelin Acetate to Radiotherapy for Patients with Oligo-recurrent Prostate Cancer with Up to 4 Metastases
The NetherlandsStudy of Sasanlimab Treatment as a Bladder-Sparing Strategy in Patients with Muscle Invasive Bladder Cancer
SpainStudy Comparing Venetoclax and Obinutuzumab with Drug Combination for Fit Patients with Untreated Chronic Lymphocytic Leukemia Without Specific Genetic Mutations
FranceStudy on the Safety and Effects of AMT-130 for Adults with Early Huntington's Disease
PolandStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
AustriaLong-Term Safety and Efficacy Study of Nedosiran Injection for Patients with Primary Hyperoxaluria
FranceStudy on Darolutamide with Standard Therapy for Patients with High-Risk Localized Prostate Cancer
IrelandStudy of Rapcabtagene Autoleucel and Ibrutinib for Adults with Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Other Blood Cancers
AustriaStudy of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer
SpainStudy on Reduced Dose Intensity of Pembrolizumab and Drug Combination for Patients with Advanced or Metastatic Cancer Responding to Standard Immunotherapy
FranceStudy on Itacitinib for Treating Non-Severe Hemophagocytic Lymphohistiocytosis in Adults
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
